The authors did emphasize that they were not ruling on the overall “clinical efficacy” of hydroxychloroquine with this research. 

Researchers wrote that they observed "substantial and increasing disparities in CVD between people with the most resources and the remainder of the U.S. population."

The latest evidence of COVID-19's cardiovascular impact on patients comes from a new imaging study published in the American Journal of Roentgenology.

The study's authors identified dozens of potential new biomarkers, sharing their findings in the Proceedings of the National Academy of Sciences.

Gary Idelchik, MD, has filed a lawsuit against BayCare Health System in Florida.

The map, part of a study published in Nature, can provide new details about cellular structure and how cells interact with one another. It could even help with the treatment of COVID-19. 

One key detail is that no stent thrombosis events were reported among the study's 201 participants. 

The study's authors urged physicians to use caution when prescribing these medications for "off-label indications." 

The study tracked nearly 500 patients for more than two decades. 

The transplant, performed at UC San Diego Health, was part of an ongoing clinical trial. 

It’s likely that cardiologists will become quite familiar with the Digital Health Center of Excellence in the years ahead.

The study focused on more than 1,400 TAVR patients treated from August 2007 to June 2018.